Clinical effects of Sanqi wound tablets combing with Western medicine to conservative treatment of acute thalamic hemorrhage
10.3969/j.issn.1005-1678.2017.05.051
- VernacularTitle:三七伤药片联合西药保守治疗急性丘脑出血的临床效果观察
- Author:
Jian ZHOU
;
Mingjie HU
;
Jiacheng QIAN
- Keywords:
Sanqi wound tablets;
thalamic hemorrhage;
inflammation;
conservative treatment
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):155-157
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe clinical effects of Sanqi wound tablets combing with Western medicine to conservative treatment of acute thalamic hemorrhage.Methods72 patients with acute thalamic hemorrhage from Department of Neurosurgery from December 2014-June 2016 were grouped two groups by random number table method.The control group was treated with Western medicine, and observation group was treated with Sanqi wound tablets combing with Western medicine.Relevant indicators were analyzed between two groups.ResultsEffective rate of observation group was 88.89%, higher than control group with 69.44%(P<0.05).NSE and hs-CRP level of observation group were (7.02±1.86)μg/L,(11.75±2.64)mg/L, lower than control group(13.98±2.01)g/L,(19.82±3.07)mg/L(all P<0.05).Fugl-Meyer and NIHSS of observation group were (93.07±4.25),(12.01±2.30)points, better than control group(81.16±4.10),(18.42±2.45)points(all P<0.05).Thalamic residual bleeding of observation group was (2.82±0.41)mL, lower than control group (3.97±0.57)mL(P<0.05).ConclusionOn the basis of Western medicine, Sanqi wound tablets can improve the therapeutic effect, reduce inflammation, improve the patient's motor function and nerve defect degree and accelerate the absorption of hematoma.
